![Microscope](https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_200_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=dP5yWnc- 200w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_260_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=bVJHY_Ft 260w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_320_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=Yi0mZ-Kz 320w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_400_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=86V2TdSk 400w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_520_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=tNvEM2Kp 520w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_640_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=xXMLjTj7 640w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_800_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=4sen7K-j 800w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_1040_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=5q781Eh5 1040w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_1280_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=p9la3QVp 1280w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_1600_21_9/public/media/images/2022-09/lipkintaskforce092022-1500x632.jpg?itok=R4sOo_GW 1600w)
W. Ian Lipkin Joins Taskforce to Address Risks of Lab-Based Pathogen Outbreaks
W. Ian Lipkin, John Snow Professor of Epidemiology and director of the Center for Infection and Immunity at Columbia Mailman School, is one of a group of scientists and public health leaders convened by the Bulletin of the Atomic Scientists to be part of a new international task force to consider trends and oversight of high-risk pathogen research.
The announcement follows the WHO’s recent release of the “Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research.” Over the next few months, the initiative on “Creating the Framework for Tomorrow’s Pathogen Research” will discuss risk assessment and mitigation, including lab-based outbreak risks.
A public-facing conference in Geneva, Switzerland, in April will include task force members, policy leaders, journalists, scientists, and civic leaders, among others, and will produce a summary report with recommendations for a comprehensive global approach to the management of extremely high-risk biological research. (Read more on the Bulletin website.)